Verastem (VSTM) EBT Margin (2018 - 2026)
Verastem's (VSTM) quarterly EBT Margin came in at 238.1% in Q1 2026, down 2.36% quarter-over-quarter from 232.6% in Q4 2025.
Verastem (VSTM) EBT Margin (2018 - 2026) Analysis & Trends
Verastem's EBT Margin history runs 8 years deep, the most recent figure standing at 238.1% for Q1 2026.
- On a quarterly basis, EBT Margin changed N/A year-over-year to 238.1% in Q1 2026; TTM through Mar 2026 was 370.01%, a N/A change from a year earlier, with the FY2025 full-year figure at 677.59%, up 62693.0% from the prior year.
- EBT Margin declined to 238.1% in Q1 2026 per VSTM's latest filing, from 232.6% in the prior quarter.
- Across five years, EBT Margin topped out at 184.32% in Q2 2024 and bottomed at 2524.61% in Q2 2025.
- The 4-year median for EBT Margin is 315.97% (2026), against an average of 705.95%.
- Across the five-year window, EBT Margin jumped 130151 bps in 2022 and sank 234029 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 662.21% in 2022, then surged by 72 bps to 184.32% in 2024, then retreated by 26 bps to 232.6% in 2025, then slipped by 2 bps to 238.1% in 2026.
- Per Business Quant, the three latest VSTM EBT Margin figures stand at 238.1% (Q1 2026), 232.6% (Q4 2025), and 393.84% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | -238.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -238.10% |
| Dec 31, 2025 | -232.60% |
| Sep 30, 2025 | -393.84% |
| Jun 30, 2025 | -2,524.61% |
| Jun 30, 2024 | -184.32% |
| Mar 31, 2022 | -662.21% |
| Dec 31, 2021 | -3,024.04% |
| Sep 30, 2021 | -1,247,300.00% |
| Jun 30, 2021 | -6,956.20% |
| Mar 31, 2021 | -1,963.72% |
| Dec 31, 2020 | -3,887.35% |
| Sep 30, 2020 | 16.71% |
| Jun 30, 2020 | -534.25% |
| Mar 31, 2020 | -751.38% |
| Dec 31, 2019 | -1,054.27% |
| Sep 30, 2019 | -333.69% |
| Jun 30, 2019 | -1,345.47% |
| Mar 31, 2019 | -2,280.19% |
| Dec 31, 2018 | -3,050.00% |
| Sep 30, 2018 | -373.36% |